Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Revenue Breakdown

Chart: Revenue Breakdown for Madrigal Pharmaceuticals. Values in USD billions. In Q2 2026: Revenue 0.364, Gross Profit 0.324, Operating Income -0.056.

Revenue Flow

Chart: Revenue Flow for Madrigal Pharmaceuticals. Q2 2026, values in USD. Revenue 59%, Gross Profit 53%, Cost of Revenue 7%, Operating Income -9%, Net Income -9%.

Balance Sheet

Chart: Balance Sheet for Madrigal Pharmaceuticals. Values in currency. In Q2 2026: Total Assets 1.245, Total Liabilities 0.721, Total Equity 0.524.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Madrigal Pharmaceuticals. Values in currency. In Q2 2026: Operating Cash Flow 0.023, Free Cash Flow 0.019, Capital Expenditures 0.004.

Q3 2016-Q2 2026

Madrigal Pharmaceuticals (MDGL) - Compare | Sterling

Revenue Breakdown

Chart: Revenue Breakdown for Madrigal Pharmaceuticals. Values in USD billions. In Q2 2026: Revenue 0.364, Gross Profit 0.324, Operating Income -0.056.

Revenue Flow

Chart: Revenue Flow for Madrigal Pharmaceuticals. Q2 2026, values in USD. Revenue 59%, Gross Profit 53%, Cost of Revenue 7%, Operating Income -9%, Net Income -9%.

Balance Sheet

Chart: Balance Sheet for Madrigal Pharmaceuticals. Values in currency. In Q2 2026: Total Assets 1.245, Total Liabilities 0.721, Total Equity 0.524.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Madrigal Pharmaceuticals. Values in currency. In Q2 2026: Operating Cash Flow 0.023, Free Cash Flow 0.019, Capital Expenditures 0.004.

Q3 2016-Q2 2026